A-796,260
id:
a-796-260-236-12007599
title:
A-796,260
text:
A-796,260 is a drug developed by Abbott Laboratories that acts as a potent and selective cannabinoid CB2 receptor agonist. Replacing the aromatic 3-benzoyl or 3-naphthoyl group found in most indole derived cannabinoids with the 3-tetramethylcyclopropylmethanone group, imparts significant selectivity for CB2, and A-796,260 was found to be a highly selective CB2 agonist with little affinity for CB1, having a CB2 Ki of 4.6 nM vs 945 nM at CB1. It has potent analgesic and anti-inflammatory actions i
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/A-796,260
date created:
date modified:
2024-02-08T21:31:29Z
main entity:
{"identifier":"Q4646876","url":"https://www.wikidata.org/entity/Q4646876"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/39/A-796260_structure.png","width":362,"height":506}
fields total:
13
integrity:
15